Ignite Creation Date:
2025-12-25 @ 3:26 AM
Ignite Modification Date:
2026-02-13 @ 2:32 PM
Study NCT ID:
NCT06841705
Status:
RECRUITING
Last Update Posted:
2025-11-04
First Post:
2025-02-11
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Early Vedolizumab as First-Line for Immune-Related Colitis Therapy Trial
Sponsor:
Shilpa Grover, MD, MPH
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Immune Checkpoint Inhibitor-Related Colitis | View |